NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Analyst Ratings
Europe - FRA:NZM2 - DK0060336014 - Common Stock
51.94 EUR
+0.72 (+1.41%)
ChartMill assigns a Buy % Consensus number of 75% to NZM2.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 64.69. This target is 24.55% above the current price.
NZM2.DE was analyzed by 22 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about NZM2.DE.
In the previous month the buy percentage consensus was at a similar level.
NZM2.DE was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
NOVONESIS (NOVOZYMES) B / NZM2.DE FAQ
What is the price target for NZM2 stock?
22 analysts have analysed NZM2.DE and the average price target is 64.69 EUR. This implies a price increase of 24.55% is expected in the next year compared to the current price of 51.94.
What is the consensus rating for NOVONESIS (NOVOZYMES) B (NZM2.DE) stock?
The consensus rating for NOVONESIS (NOVOZYMES) B (NZM2.DE) is 74.5455 / 100 . This indicates that analysts generally have a positive outlook on the stock.